Trial intelligence / Profile preview

Metformin-FMD trial

2011-005343-27Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metformin in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started Jan 2012; status: completed.

02

Drugs

metformin
03

Conditions

ischemia-reperfusion injury (IRI)

Beyond the preview

Go deeper on 2011-005343-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005343-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call